Resultados da busca - Fiona Taylor
- Mostrando 1 - 20 resultados de 35
- Ir para a próxima página
-
1
Proforma-based reporting in rectal cancer por Fiona Taylor
Publicado em 2010Revisão -
2
-
3
-
4
-
5
-
6
-
7
Promoting patient uptake and adherence in cardiac rehabilitation por Philippa Davies, Fiona Taylor, Andrew D Beswick, Frances Wise, T Moxham, Karen Rees, Shah Ebrahim
Publicado em 2010Revisão -
8
-
9
Reduced dietary salt for the prevention of cardiovascular disease por Alma J Adler, Fiona Taylor, Nicole Martin, Sheldon H. Gottlieb, Rod S Taylor, Shah Ebrahim
Publicado em 2014Revisão -
10
-
11
-
12
Statins for the primary prevention of cardiovascular disease por Fiona Taylor, Kirsten Ward, Theresa HM Moore, Margaret Burke, George Davey Smith, Juan P. Casas, Shah Ebrahim
Publicado em 2011Referência Bibliográfica -
13
Impact of Nivolumab versus Docetaxel on Health-Related Quality of Life and Symptoms in Patients with Advanced Squamous Non–Small Cell Lung Cancer: Results from the CheckMate 017 St... por Martin Reck, Fiona Taylor, John R. Penrod, Michael DeRosa, L Morrissey, Homa Dastani, Lucinda Orsini, Richard J. Gralla
Publicado em 2017Artigo -
14
-
15
One millimetre is the safe cut-off for magnetic resonance imaging prediction of surgical margin status in rectal cancer por Fiona Taylor, Philip Quirke, Richard J. Heald, Brendan Moran, Lennart Blomqvist, I. Swift, Suzanne Rose, David Sebag‐Montefiore, Paris Tekkis, Gina Brown
Publicado em 2011Artigo -
16
Provision, uptake and cost of cardiac rehabilitation programmes: improving services to under-represented groups por Andrew D Beswick, Karen Rees, Ingolf Griebsch, Fiona Taylor, Matthew J. Burke, Robert West, Jack Victory, Jacqueline Brown, R Taylor, Shanil Ebrahim
Publicado em 2004Revisão -
17
PD1.01 (also presented as P2.46): LCSS as a Marker of Treatment Benefit With Nivolumab vs Docetaxel in Pts With Advanced Non-Squamous NSCLC From Checkmate 057 por Richard J. Gralla, David R. Spigel, Bryan Bennett, Fiona Taylor, John R. Penrod, Michael DeRosa, Homa Dastani, Lucinda Orsini, Clarissa Mathias, Martin Reck
Publicado em 2016Artigo -
18
P2.46 (also presented as PD1.01): LCSS as a Marker of Treatment Benefit With Nivolumab vs Docetaxel in Pts With Advanced Non-Squamous NSCLC From Checkmate 057 por Richard J. Gralla, David R. Spigel, Bryan Bennett, Fiona Taylor, John R. Penrod, Michael DeRosa, Homa Dastani, Lucinda Orsini, Clarissa Mathias, Martin Reck
Publicado em 2016Artigo -
19
Magnetic Resonance Imaging–Detected Tumor Response for Locally Advanced Rectal Cancer Predicts Survival Outcomes: MERCURY Experience por Uday Patel, Fiona Taylor, Lennart Blomqvist, Christopher George, Hywel Evans, Paris Tekkis, Philip Quirke, David Sebag‐Montefiore, Brendan Moran, Richard J. Heald, Ashley Guthrie, Nicola Bees, Ian Swift, Kjell Pennert, Gina Brown
Publicado em 2011Artigo -
20
Effect of nivolumab on health-related quality of life in patients with treatment-naïve advanced melanoma: results from the phase III CheckMate 066 study por Georgina V. Long, Victoria Atkinson, Paolo A. Ascierto, Caroline Robert, J.C. Hassel, Piotr Rutkowski, Kerry J. Savage, Fiona Taylor, Cheryl D. Coon, I. Gilloteau, Homa Dastani, Ian M. Waxman, Amy P. Abernethy
Publicado em 2016Artigo
Ferramentas de busca:
Assuntos relacionados
Medicine
Internal medicine
Oncology
Lung cancer
Cancer
Randomized controlled trial
Immunotherapy
Nivolumab
Confidence interval
Law
MEDLINE
Meta-analysis
Political science
Biology
Cochrane Library
Disease
Environmental health
Nursing
Physical therapy
Psychiatry
Psychological intervention
Surgery
Angina
Clinical trial
Intensive care medicine
Myocardial infarction
Pathology
Chemotherapy
Colorectal cancer
Computational biology